In addition to effects on tumor cell proliferation, we observed larger necrotic areas within the primary tumors of Sangivamycin treated mice (Fig. 5E), which may be due to collapsed vasculature structures as determined with anti-CD31 immunohistochemistry (Supplemental Fig. S3C). The gene discussed is PECAM1; the disease is neoplasm.